Currently out of the existing stock ratings of Samuel Brodovsky, 13 are a BUY (56.52%), 10 are a HOLD (43.48%).

Samuel Brodovsky

Work Performance Price Targets & Ratings Chart

Analyst Samuel Brodovsky works at TRUIST with a stock forecast success ratio of 61.54% fulfilled within 87 days on average.

Samuel Brodovsky’s has documented 46 price targets and ratings displayed on 3 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on KIDS, Orthopediatrics Corp at 08-May-2024.

Wall Street Analyst Samuel Brodovsky

Analyst best performing recommendations are on VCEL (VERICEL CORP ORD).
The best stock recommendation documented was for VCEL (VERICEL CORP ORD) at 1/31/2023. The price target of $29 was fulfilled within 2 days with a profit of $1.53 (5.57%) receiving and performance score of 27.85.

Average potential price target upside

KIDS Orthopediatrics Corp VCEL Vericel Corp Ord GKOS Glaukos Corp

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

38

$5.98 (18.68%)

56

10 days ago

1/5 (20%)

$4.82 (14.53%)

91

Buy

42

$9.98 (31.17%)

37

11 days ago

6/13 (46.15%)

$7.3 (21.04%)

172

Buy

50

$17.98 (56.15%)

50

11 days ago

2/10 (20%)

$15.3 (44.09%)

58

Buy

34

$1.98 (6.18%)

50

2 months 11 days ago

6/6 (100%)

$5.27 (18.34%)

89

Hold

52

3 months 23 days ago

1/3 (33.33%)

$7.94 (18.02%)

181

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Samuel Brodovsky is most bullish on?

Potential upside of $15.21 has been obtained for GKOS (GLAUKOS CORP)

Which stock is Samuel Brodovsky is most reserved on?

Potential downside of $5.65 has been obtained for VCEL (VERICEL CORP ORD)

What Year was the first public recommendation made by Samuel Brodovsky?

On 2020

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?